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Introduction
• Diabetic ketoacidosis (DKA) is known to cause mild elevations in triglyceride 
levels. 
• Severe hypertriglyceridemia (HTG) is a well-known cause of acute pancreatitis 
however, in unique cases, DKA has been shown to cause severe HTG leading 
to the development of acute pancreatitis (AP). 
• HTG causing AP only accounts for 1-4% of cases of AP
• From the few cases in literature that have reported this triad of DKA, HTG, 
and AP, even fewer have shown to be successfully treated with insulin therapy 
alone with the severe degree of HTG that we discuss. 
Case Presentation
• A 20-year-old Caucasian female who presented for evaluation of 2-day history 
of worsening epigastric pain, associated with nausea and vomiting. She has a 
pmh significant for SLE and a family history significant for HLD. Social 
history was negative for alcohol or tobacco dependence. Patient had a RUQ 
ultrasound which showed AP and a confirmatory CT abdomen and pelvis 
which showed severe AP of the distal body and tail of the pancreas.
• Labs was significant for a blood glucose 370 mg/dL, high anion gap metabolic 
acidosis (anion gap 21), lipase of 1095 U/L, triglyceride level of 16076 mg/dL, 
cholesterol 1629 mg/dL and HbA1c of 11.2%.
• She was diagnosed with AP and admitted to the ICU for treatment with 
intravenous insulin infusion for the treatment of DKA and HTG with 
aggressive IV fluids and electrolyte replacement. 
• Patient’s DKA resolved and her triglyceride levels decreased from 16076 to 
283 mg/dL over the next 5 days.
Imaging and Labs
Figure 1. (A, B): Computed tomography images showing pancreatic inflammation 
and edema (arrows) surrounding the head and tail of the pancreas
Pathophysiology
• DKA is known to cause mild elevations in triglyceride levels via insulin 
deficiency however severe HTG (> 2000 mg/dL) is rare. 
• Insulin deficiency seen in DKA leads to the production of free fatty acids and 
amino acids from adipose and muscle tissue. 
• As these free fatty acids (FFA) are circulating in the blood they get taken up by 
the liver and leads to increased production of very low density lipoproteins 
(VLDL) which causes HTG. 
• Insulin deficiency also reduces the activity of lipoprotein lipase in peripheral 
tissues leading to decreased removal of VLDL from plasma which allows more 
time for liver uptake. (1)
• Even though the true mechanism is still not clear, It has been proposed that 
high concentrations of toxic free fatty acids generated from the breakdown of 
triglycerides by pancreatic lipase contributes to pancreatic cell injury (2)
Treatment
• Management includes aggressive fluid administration, electrolyte repletion 
and intravenous insulin infusion. Studies show that other treatment options 
include low-molecular-weight heparin, therapeutic plasma exchange, and 
double-filtration. (3)
• Plasmapheresis is considered especially those with organ failure such as renal 
insufficiency, who failed with conservative treatment as mentioned above. (4)
• The use of lipid-lowering agents, such as fibrates, can be used in most 
conditions accompanied by HTG but not beneficial in patients with 
lipoprotein lipase deficiency (5)
• Omega oils are essential fatty acid naturally present in fish, algae, and other 
seafood; their use as a TG-lowering drug in the management of severe HTG is 
recommended by both the National Lipid Association and the American Heart 
Association (6)
Discussion
• Previous studies have shown that an estimated mortality rate of up to 80% 
can be seen in patients with AP and co-existing DKA (2). 
• Therapeutic plasma exchange (TPE) or plasmapheresis is the modality of 
choice for treating patients with pancreatitis due to severe HTG as it involves 
the removal of plasma and substitutes it with a colloid solution such as 
donated plasma or albumin. 
• TPE is associated with increased cost, availability issues, and its mortality 
benefits have not been completely established. In many cases, patients are 
transferred to another institution for management. 
• IV insulin therapy is used until triglyceride levels are less than 500 mg/dL, 
however its use in severely elevated HTG has not been well studied in the 
literature. In our case, we were able to successfully and safely lower severely 
elevated triglyceride levels without the need for plasmapheresis.
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Conclusion
In our case, we have treated a triad of DKA, AP and severe HTG with a value of 
16076 mg/dL with insulin therapy alone which has not been documented in our 
literature search.
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(C): The role of insulin deficiency in causing HTG leading to AP. Decreased 
inhibition  hormone-sensitive lipase leads to increased FFA which will be 
converted to serum HTG causing AP. (3)
